Advances in Oral Anti-Diabetes Drugs in Pregnancy-Reference-Cited by-同舟云学术

Advances in Oral Anti-Diabetes Drugs in Pregnancy

Published:2017-09-20 Issue: Volume: Page:189-201
ISSN:
Container-title:A Practical Manual of Diabetes in Pregnancy
language:
Short-container-title:

Author:

Mukerji Geetha¹,Feig Denice S.²

Affiliation:

1. University of Toronto; Women's College Hospital; and Mount Sinai Hospital (cross-appointed); Toronto Canada

2. University of Toronto; Diabetes & Endocrinology in Pregnancy Program; and Mount Sinai Hospital; Toronto Canada

Publisher

John Wiley & Sons, Ltd

Reference65 articles.

1. Diabetes and pregnancy: an endocrine society clinical practice guideline;Blumer;J Clin Endocrinol Metab,2013

2. Centers for Disease Control and Prevention Diabetes Public Health Resource: Age-adjusted rates of diagnosed diabetes per 100 civilian, non-institutionalized population, by race and sex, United States, 1980-2014 http://www.cdc.gov/diabetes/statistics/prev/national/figraceethsex.htm

3. Favorable effects of glibenclamide in a patient exhibiting idiosyncratic hepatotoxic reactions to both chlorpropamide and tolbutamide;Rumboldt;Acta Diabetolog Latina,1984

4. The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus;Guardado-Mendoza;Arch Med Sci,2013

5. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes;Fuhlendorff;Diabetes,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacokinetics of glipizide: a systematic review;Expert Opinion on Drug Metabolism & Toxicology;2024-09-12

2. Gestational Diabetes Mellitus—Recent Literature Review;Journal of Clinical Medicine;2022-09-28